Your standard lipid panel measures LDL cholesterol — the amount of cholesterol inside particles. ApoB counts the particles themselves. In the people who need it most, those two numbers point in very different directions.
Think of LDL particles as cars. LDL cholesterol measures the total amount of cargo (cholesterol) those cars are carrying. ApoB counts the cars themselves. Cardiovascular risk is primarily driven by how many cars are on the road — not how much cargo each car carries. A highway jammed with lightly loaded cars is more dangerous than one with fewer, fully loaded cars.
| LDL-C (LDL cholesterol) | ApoB | |
|---|---|---|
| What it measures | Cholesterol content inside LDL particles | Number of atherogenic lipoprotein particles (LDL, VLDL, IDL, Lp(a)) |
| Units | mg/dL (cholesterol mass) | mg/dL (protein mass — proxy for particle count) |
| In standard panel | ✓ Always included | ✗ Must order separately |
| Optimal level | Under 100 mg/dL (standard) / under 70 mg/dL (high risk) | Under 80 mg/dL / under 70 mg/dL (risk factors) |
| Responds to lifestyle | ✓ Yes | ✓ Yes |
| Affected by insulin resistance | Can appear falsely normal | Reveals true particle burden |
| Can be discordant from LDL-C | — | ✓ In metabolically unhealthy individuals |
| 2026 ACC/AHA guideline position | Primary metric | Superior for residual risk assessment |
| Cost to order (Quest Health) | Included in standard lipid panel | ~$30–40 separately |
Reference ranges vary by lab, age, sex, and clinical context. Use these as starting points for a conversation with your clinician, not as diagnosis.
The critical insight is discordance — when LDL-C and ApoB point in opposite directions. This happens commonly in people with:
When triglycerides are elevated, the liver produces more smaller, denser LDL particles. Each particle carries less cholesterol, so LDL-C appears normal or even low. But ApoB — which counts every particle — reveals the true burden. This person has high cardiovascular risk that LDL-C misses entirely. This is the most clinically significant discordance pattern and affects a large proportion of adults over 40.
A person can have excellent LDL-C and HDL-C but still have high ApoB driven by elevated VLDL and IDL particles. The standard panel looks reassuring. ApoB reveals the hidden burden.
In people with normal triglycerides, no insulin resistance, and no metabolic syndrome, LDL-C and ApoB correlate closely. The additional information from ApoB is less critical in this population. If you are metabolically healthy with normal triglycerides, LDL-C is an adequate screening marker. But if you have any metabolic dysfunction, ApoB is essential.
The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline — the first major update since 2018 — elevated ApoB's clinical role. The guideline designates ApoB as a superior marker for residual cardiovascular risk assessment, particularly in people with metabolic syndrome, insulin resistance, or high triglycerides. It supports using ApoB as a treatment target alongside LDL-C in high-risk patients.
This is a meaningful shift. For the first time, major US guidelines explicitly position ApoB as a primary — not secondary — tool for cardiovascular risk management in certain populations. Clinical adoption will lag, as it always does. But the standard of care is moving toward particle-count metrics.
Gives you LDL-C, HDL-C, total cholesterol, and triglycerides. Ask your doctor to include it if not ordered automatically. No additional cost with most insurance plans.
Ask your doctor specifically for "Apolipoprotein B." Order direct: Quest Health offers ApoB without a prescription for ~$30–40. Function Health includes it in the annual panel alongside 160+ other biomarkers.
Order ApoB — Quest Health →
ApoB and fasting insulin together reveal the full metabolic + cardiovascular picture. If fasting insulin is above 7 µIU/mL, the mechanism driving elevated ApoB (insulin resistance producing small dense LDL) is likely operative. Both tests can be ordered on the same blood draw. Both require fasting for the draw.
ApoB, Lp(a), and fasting insulin — the three key markers not in standard lipid panels — ordered directly without a doctor.